WHOOP
FDA closes warning letter over Whoop blood pressure insights
The FDA formally closed the July 2025 warning letter that challenged Whoop's Blood Pressure Insights feature, with founder and CEO Will Ahmed announcing the resolution on LinkedIn. Whoop maintained the feature was a wellness offering, not a regulated medical device.
View Original